What is the current Traditional influenza diagnostic market size?

The Traditional influenza diagnostic market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Traditional influenza diagnostic market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Traditional influenza diagnostic market?

Key drivers include rising influenza cases, advances in diagnostic technologies, and growing healthcare expenditure.

What are the major challenges facing the Traditional influenza diagnostic market?

Challenges include high costs, limited accessibility, and intense competition among market players.

Which regions are the leaders in the Traditional influenza diagnostic market?

North America and Europe are the leading regions, due to well-established healthcare infrastructure.

Who are the top companies in the Traditional influenza diagnostic market?

Top companies include Roche, Abbott, and Siemens, which offer a wide range of diagnostic products.

What are the future opportunities in the Traditional influenza diagnostic market?

Future opportunities include emerging markets, point-of-care diagnostics, and molecular testing technologies.

How is technology impacting the Traditional influenza diagnostic market?

Technology is driving the market with advances in PCR, serology, and other diagnostic techniques.

What is the current regulatory landscape for the Traditional influenza diagnostic market?

The regulatory landscape is governed by FDA, CE, and other regional authorities, ensuring safety and efficacy.

What is the future outlook for the Traditional influenza diagnostic market?

The future outlook is positive, with increasing demand for diagnostic products and growing awareness.

Traditional influenza diagnostic - Strategic Insights: Analysis 2025 and Forecasts 2033

Traditional influenza diagnostic by Application (Hospitals, POCT, Others), by Types (Rapid Influenza Detection Tests, Viral Culture, Direct Fluorescent Antibody (DFA) Tests, Serological Assays), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Traditional influenza diagnostic Market Overview

The Traditional influenza diagnostic market refers to the industry that provides diagnostic solutions for influenza, a highly contagious respiratory illness. As the Traditional influenza diagnostic market size is expected to reach $1.4 billion by 2026, the growth outlook for this industry is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2026 to 2033. The industry expansion is driven by the increasing prevalence of influenza, advancements in diagnostic technologies, and growing demand for rapid and accurate diagnostic tests. The scope of this market includes various diagnostic technologies, such as rapid influenza diagnostic tests (RIDTs), molecular assays, and serological tests, which are used in hospitals, clinics, and laboratories.

Loading chart…

The Traditional influenza diagnostic market is influenced by several key forces, including technology shifts towards more rapid and accurate diagnostic tests, regulations that drive the adoption of certain diagnostic technologies, and consumer behavior that demands more convenient and accessible diagnostic solutions. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific. The growth of this market is expected to be driven by the increasing prevalence of influenza, advancements in diagnostic technologies, and growing demand for rapid and accurate diagnostic tests. As the Traditional influenza diagnostic market size continues to grow, it is essential for industry players to stay ahead of the competition by investing in research and development, expanding their product portfolios, and establishing strong distribution networks.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.19 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Abbott (Include Alere) Abbott; Roche; SIEMENS; Analytik Jena; Quidel; Thermo Fisher; Meridian Bioscience; BioMerieux; Sekisui Diagnostics; Response Biomedical; SA Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Traditional influenza diagnostic market is poised for significant growth, driven by increasing demand for rapid and accurate diagnostic solutions. The market dynamics are shaped by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in molecular diagnostics are enhancing the accuracy and speed of traditional influenza diagnostic methods, driving the Traditional influenza diagnostic market size and growth forecast.

Government initiatives and public health campaigns are increasing awareness about the importance of influenza diagnosis and treatment, contributing to the growth of the Traditional influenza diagnostic market.

Restraints2 items

The high cost of traditional diagnostic methods is a significant restraint, limiting access to these solutions in resource-constrained settings and affecting the overall Traditional influenza diagnostic market size.

The availability of alternative diagnostic methods, such as point-of-care tests, is also hindering the growth of the Traditional influenza diagnostic market.

Opportunities2 items

The increasing prevalence of influenza in developing countries presents a significant opportunity for the Traditional influenza diagnostic market to expand its reach and improve healthcare outcomes.

The growing demand for rapid diagnostic solutions in emergency care settings is also creating new opportunities for the Traditional influenza diagnostic market to innovate and grow.

Challenges2 items

The Traditional influenza diagnostic market faces significant challenges in terms of regulatory compliance, with evolving regulations and standards impacting the development and commercialization of diagnostic solutions.

The global supply chain disruptions are also affecting the Traditional influenza diagnostic market, leading to shortages of critical components and impacting the growth forecast.

Market Segmentation

Loading chart…

The Traditional influenza diagnostic market can be segmented based on Application, which refers to the different uses of influenza diagnostic tests. This segmentation category contributes to the overall Traditional influenza diagnostic market size by highlighting the various areas where these tests are applied, such as hospitals, laboratories, and research institutions. Understanding the application segment is crucial for market players to identify opportunities and develop targeted strategies. The Traditional influenza diagnostic segmentation by application includes point-of-care testing, molecular diagnostic testing, and other applications.

Another significant segmentation category in the Traditional influenza diagnostic market is Types, which encompasses various subtypes of influenza diagnostic tests. These subtypes include rapid influenza diagnostic tests (RIDTs), enzyme immunoassays (EIAs), and immunofluorescence assays. Each subtype has its own strengths and weaknesses, and understanding these differences is essential for market players to develop effective products and marketing strategies. The types segment contributes to the overall market size by providing insights into the different technologies and methods used for influenza diagnosis, allowing market players to identify areas for innovation and growth. The market taxonomy of Traditional influenza diagnostic types is critical for understanding the competitive landscape and identifying opportunities for expansion.

Traditional influenza diagnostic Segmentation Breakdown9 items

Application

Hospitals

POCT

Others

Types

Rapid Influenza Detection Tests

Viral Culture

Direct Fluorescent Antibody (DFA) Tests

Serological Assays

Regional Insights

Loading chart…

The Traditional influenza diagnostic market is poised for significant growth, driven by increasing demand for accurate and rapid diagnostic solutions. The largest region, North America, accounts for approximately 35% of the market share, driven by key drivers such as high adoption rates of advanced diagnostic technologies, favorable policies supporting healthcare infrastructure development, and substantial investments in research and development. The fastest-growing region, Asia Pacific, is expected to drive Traditional influenza diagnostic market growth with a forecasted CAGR of 10%, driven by growing demographics, improving infrastructure, and increasing ecosystem maturity.

In Europe, key drivers include increasing awareness of infectious diseases, policies supporting public health initiatives, and investments in digital health technologies. Latin America is driven by growing demographics, increasing access to healthcare services, and improving infrastructure. Middle East & Africa is driven by government initiatives to strengthen healthcare systems, increasing adoption of digital health technologies, and growing ecosystem maturity.

Regional Forecast5 items

North America: 35% market share, driven by high adoption rates and favorable policies

Asia Pacific: fastest-growing region, driven by growing demographics and improving infrastructure

Europe: driven by increasing awareness of infectious diseases and investments in digital health technologies

Latin America: driven by growing demographics and increasing access to healthcare services

Middle East & Africa: driven by government initiatives to strengthen healthcare systems

Competitive Landscape

The Traditional influenza diagnostic competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of these factors, with global players focusing on product innovation and local companies competing on pricing and distribution. The Traditional influenza diagnostic key players are leveraging their strengths in these areas to maintain their market position.

Companies in this market are employing various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing these strategies:

BD: regional expansion

Abbott: innovation pipeline

Roche: premium pricing

SIEMENS: OEM tie-ups

Analytik Jena: local manufacturing

Quidel: vertical integration

Key Traditional influenza diagnostic Companies12 items

Abbott (Include Alere) Abbott

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Market Ecosystem

The Traditional influenza diagnostic ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem is characterized by a linear value chain, where value is created and captured through the development, manufacturing, and distribution of diagnostic products. The ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with each stage comprising distinct participants that contribute to the overall flow of value.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — develop and produce diagnostic products

Technology providers — offer innovative diagnostic technologies

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish diagnostic standards and guidelines

End users / buyers — purchase and utilize diagnostic products

In the Traditional influenza diagnostic ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the adoption of diagnostic products through stringent approvals and guidelines. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact product development and distribution. Furthermore, switching costs and partnerships can be significant, as end users often require customized solutions and may be locked into specific diagnostic systems. A thorough value chain analysis is essential to understanding these intricacies and navigating the Traditional influenza diagnostic ecosystem, particularly as it differs by region due to varying regulatory requirements and market dynamics.

Recent Industry Insights

The Traditional influenza diagnostic industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as collaborations between leading diagnostic companies and research institutions, have driven innovation in the field. Furthermore, mergers and acquisitions have led to consolidation, enabling companies to expand their product portfolios and enhance their market presence. Recent product launches, including rapid diagnostic tests and molecular assays, have improved diagnostic accuracy and speed.

Regulatory changes, such as updated guidelines for diagnostic test approval, have also impacted the industry. Additionally, a shift in consumer trends towards point-of-care testing has driven demand for portable and user-friendly diagnostic solutions. Funding rounds and expansions have supported the growth of companies in this space, enabling them to invest in research and development and commercialization efforts.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Traditional influenza diagnostic market outlook is that it presents a moderately attractive opportunity, driven by the ongoing need for rapid and accurate diagnostic solutions. The competitive intensity in this market is high, with several established players competing for market share.

Looking ahead, the long-term outlook for the Traditional influenza diagnostic market is promising, with increasing demand for diagnostic tests in emerging economies and the ongoing threat of influenza outbreaks. However, the market is not without risks, including the potential for supply chain disruptions and the emergence of new diagnostic technologies that could disrupt traditional testing methods.

In terms of innovation, the Traditional influenza diagnostic market is experiencing a period of gradual evolution, with advancements in molecular diagnostics and point-of-care testing. The demand-supply balance in the market is currently stable, but may be impacted by factors such as seasonal fluctuations in demand and supply chain constraints. Key risk factors for investors and market participants to consider include regulatory changes and technological disruptions.

11 items

1. Executive Summary

2. Traditional influenza diagnostic Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Traditional influenza diagnostic Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Traditional influenza diagnostic Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. POCT

6.1.3. Others

6.2. Global Traditional influenza diagnostic Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rapid Influenza Detection Tests

6.2.2. Viral Culture

6.2.3. Direct Fluorescent Antibody (DFA) Tests

6.2.4. Serological Assays

6.3. Global Traditional influenza diagnostic Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Traditional influenza diagnostic Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Traditional influenza diagnostic Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Traditional influenza diagnostic Market Competition by Key Manufacturers

8.1. Global Traditional influenza diagnostic Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Traditional influenza diagnostic: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott (Include Alere) Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. SIEMENS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Analytik Jena

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Quidel

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Thermo Fisher

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Meridian Bioscience

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. BioMerieux

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sekisui Diagnostics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Response Biomedical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SA Scientific

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Traditional influenza diagnostic Market

Figure 4: Global Traditional influenza diagnostic Market: Drivers

Figure 5: Global Traditional influenza diagnostic Market: Challenges

Figure 6: Global Traditional influenza diagnostic Market: Trends

Figure 7: Global Traditional influenza diagnostic Market: Opportunity

Figure 8: Global Traditional influenza diagnostic Market: Restraint

Figure 9: Global Traditional influenza diagnostic Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Traditional influenza diagnostic Market Value (USD Million) By Region

Figure 15: Global Traditional influenza diagnostic Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Traditional influenza diagnostic Market Value (USD Million) By Region

Figure 23: Global Traditional influenza diagnostic Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Traditional influenza diagnostic Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Traditional influenza diagnostic Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Traditional influenza diagnostic Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Traditional influenza diagnostic Market Value (USD Million) By Region

Table 10: Global Traditional influenza diagnostic Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Traditional influenza diagnostic Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Traditional influenza diagnostic Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Traditional influenza diagnostic Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Abbott (Include Alere) Abbott Basic Information And Sales Area

Table 33: Abbott (Include Alere) Abbott. Products Portfolio

Table 34: Roche Basic Information And Sales Area

Table 35: Roche. Products Portfolio

Table 36: SIEMENS Basic Information And Sales Area

Table 37: SIEMENS. Products Portfolio

Table 38: Analytik Jena Basic Information And Sales Area

Table 39: Analytik Jena. Products Portfolio

Table 40: Quidel Basic Information And Sales Area

Table 41: Quidel. Products Portfolio

Table 42: Thermo Fisher Basic Information And Sales Area

Table 43: Thermo Fisher. Products Portfolio

Table 44: Meridian Bioscience Basic Information And Sales Area

Table 45: Meridian Bioscience. Products Portfolio

Table 46: BioMerieux Basic Information And Sales Area

Table 47: BioMerieux. Products Portfolio

Table 48: Sekisui Diagnostics Basic Information And Sales Area

Table 49: Sekisui Diagnostics. Products Portfolio

Table 50: Response Biomedical Basic Information And Sales Area

Table 51: Response Biomedical. Products Portfolio

Table 52: SA Scientific Basic Information And Sales Area

Table 53: SA Scientific. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Traditional influenza diagnostic Market Value (USD Million) By Region

Table 59: Global Traditional influenza diagnostic Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Traditional influenza diagnostic Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.19 million
Growth rate	CAGR of 7.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Abbott (Include Alere) Abbott; Roche; SIEMENS; Analytik Jena; Quidel; Thermo Fisher; Meridian Bioscience; BioMerieux; Sekisui Diagnostics; Response Biomedical; SA Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in molecular diagnostics are enhancing the accuracy and speed of traditional influenza diagnostic methods, driving the Traditional influenza diagnostic market size and growth forecast.

Restraints2 items

The availability of alternative diagnostic methods, such as point-of-care tests, is also hindering the growth of the Traditional influenza diagnostic market.

Opportunities2 items

The growing demand for rapid diagnostic solutions in emergency care settings is also creating new opportunities for the Traditional influenza diagnostic market to innovate and grow.

Challenges2 items

The global supply chain disruptions are also affecting the Traditional influenza diagnostic market, leading to shortages of critical components and impacting the growth forecast.

Market Segmentation

Loading chart…

Traditional influenza diagnostic Segmentation Breakdown9 items

Application

Hospitals

POCT

Others

Types

Rapid Influenza Detection Tests

Viral Culture

Direct Fluorescent Antibody (DFA) Tests

Serological Assays

Regional Insights

Loading chart…

Regional Forecast5 items

North America: 35% market share, driven by high adoption rates and favorable policies

Asia Pacific: fastest-growing region, driven by growing demographics and improving infrastructure

Europe: driven by increasing awareness of infectious diseases and investments in digital health technologies

Latin America: driven by growing demographics and increasing access to healthcare services

Middle East & Africa: driven by government initiatives to strengthen healthcare systems

Competitive Landscape

BD: regional expansion

Abbott: innovation pipeline

Roche: premium pricing

SIEMENS: OEM tie-ups

Analytik Jena: local manufacturing

Quidel: vertical integration

Key Traditional influenza diagnostic Companies12 items

Abbott (Include Alere) Abbott

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — develop and produce diagnostic products

Technology providers — offer innovative diagnostic technologies

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — facilitate product distribution

Regulators/standards bodies — establish diagnostic standards and guidelines

End users / buyers — purchase and utilize diagnostic products

Recent Industry Insights

Analyst Overview

Table of Contents